Etsuko Uematsu

425 total citations
17 papers, 330 citations indexed

About

Etsuko Uematsu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Etsuko Uematsu has authored 17 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Epidemiology. Recurrent topics in Etsuko Uematsu's work include Adipokines, Inflammation, and Metabolic Diseases (4 papers), Cardiovascular Disease and Adiposity (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Etsuko Uematsu is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (4 papers), Cardiovascular Disease and Adiposity (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Etsuko Uematsu collaborates with scholars based in Japan. Etsuko Uematsu's co-authors include Takeshi Soeki, Masataka Sata, Michio Shimabukuro, Yoichiro Hirata, Hirotsugu Yamada, Shusuke Yagi, Hirotsugu Kurobe, Daiju Fukuda, Daiju Fukuda and Tetsuzo Wakatsuki and has published in prestigious journals such as European Heart Journal, European Journal of Pharmacology and Atherosclerosis.

In The Last Decade

Etsuko Uematsu

17 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Etsuko Uematsu Japan 10 148 105 67 66 60 17 330
Jiang Shi-sen China 11 140 0.9× 83 0.8× 77 1.1× 59 0.9× 42 0.7× 29 359
Quanzhong Li China 13 139 0.9× 81 0.8× 106 1.6× 65 1.0× 34 0.6× 27 382
Ben He China 11 156 1.1× 95 0.9× 83 1.2× 94 1.4× 77 1.3× 28 465
Xiaolei Bi China 8 175 1.2× 80 0.8× 51 0.8× 99 1.5× 36 0.6× 11 375
Samuele Ambrosini Switzerland 10 230 1.6× 129 1.2× 37 0.6× 34 0.5× 71 1.2× 24 425
Mohanad Gabani United States 11 160 1.1× 91 0.9× 49 0.7× 69 1.0× 83 1.4× 15 372
Yehoshua C. Levine United States 6 156 1.1× 163 1.6× 51 0.8× 37 0.6× 84 1.4× 13 383
Maura Knapp United States 5 139 0.9× 118 1.1× 44 0.7× 28 0.4× 52 0.9× 6 339
Katsunobu Kobayashi Japan 10 202 1.4× 128 1.2× 68 1.0× 25 0.4× 126 2.1× 11 433
Wenjuan Liu China 11 215 1.5× 148 1.4× 36 0.5× 38 0.6× 30 0.5× 21 389

Countries citing papers authored by Etsuko Uematsu

Since Specialization
Citations

This map shows the geographic impact of Etsuko Uematsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etsuko Uematsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etsuko Uematsu more than expected).

Fields of papers citing papers by Etsuko Uematsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Etsuko Uematsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etsuko Uematsu. The network helps show where Etsuko Uematsu may publish in the future.

Co-authorship network of co-authors of Etsuko Uematsu

This figure shows the co-authorship network connecting the top 25 collaborators of Etsuko Uematsu. A scholar is included among the top collaborators of Etsuko Uematsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Etsuko Uematsu. Etsuko Uematsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Matsuura, Tomomi, Takeshi Soeki, Daiju Fukuda, et al.. (2021). Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial Fibrillation. Circulation Journal. 85(8). 1383–1391. 9 indexed citations
2.
Soeki, Takeshi, Kozo Matsumoto, Daiju Fukuda, et al.. (2019). P2867Vildagliptin reduces inducibility of atrial fibrillation in hypertensive rats complicated with diabetes mellitus. European Heart Journal. 40(Supplement_1). 1 indexed citations
3.
Soeki, Takeshi, Tomomi Matsuura, Takeshi Tobiume, et al.. (2018). Clinical, Electrocardiographic, and Echocardiographic Parameter Combination Predicts the Onset of Atrial Fibrillation. Circulation Journal. 82(9). 2253–2258. 8 indexed citations
4.
Soeki, Takeshi, Tomomi Matsuura, Takeshi Tobiume, et al.. (2016). Relationship between local production of microRNA-328 and atrial substrate remodeling in atrial fibrillation. Journal of Cardiology. 68(6). 472–477. 35 indexed citations
5.
Shimabukuro, Michio, Hirotsugu Yamada, Etsuko Uematsu, et al.. (2016). The pathophysiological role of oxidized cholesterols in epicardial fat accumulation and cardiac dysfunction: a study in swine fed a high caloric diet with an inhibitor of intestinal cholesterol absorption, ezetimibe. The Journal of Nutritional Biochemistry. 35. 66–73. 14 indexed citations
6.
Shimabukuro, Michio, Hiromi Sato, Hirofumi Izaki, et al.. (2016). Depot‐ and gender‐specific expression of NLRP3 inflammasome and toll‐like receptors in adipose tissue of cancer patients. BioFactors. 42(4). 397–406. 10 indexed citations
7.
Fukuda, Daiju, Takeshi Soeki, Sachiko Nishimoto, et al.. (2015). Expression of NLRP3 in subcutaneous adipose tissue is associated with coronary atherosclerosis. Atherosclerosis. 242(2). 407–414. 55 indexed citations
8.
Takashima, Akira, Michio Shimabukuro, Minoru Tabata, et al.. (2014). Histopathological heterogeneity of instent restenosis in four coronary endarterectomy specimens. Cardiovascular Pathology. 24(3). 194–197. 3 indexed citations
9.
Soeki, Takeshi, Koji Yamaguchi, Toshiyuki Niki, et al.. (2014). Plasma MicroRNA-100 Is Associated With Coronary Plaque Vulnerability. Circulation Journal. 79(2). 413–418. 28 indexed citations
10.
Soeki, Takeshi, Etsuko Uematsu, Tomomi Matsuura, et al.. (2013). Pentraxin 3 is a local inflammatory marker in atrial fibrillation. Heart and Vessels. 29(5). 653–658. 17 indexed citations
11.
Ishida, Masayoshi, Michio Shimabukuro, Shusuke Yagi, et al.. (2013). MicroRNA-100 regulates a cluster of adipocytokine expression: A human biopsy study in subcutaneous and visceral adipose tissue. European Heart Journal. 34(suppl 1). P3265–P3265. 2 indexed citations
12.
Ishida, Masayoshi, Michio Shimabukuro, Shusuke Yagi, et al.. (2013). MicroRNA miR-378 regulates adipocytokine fate by targeting transcriptional factors in human visceral and subctaneous adipose tissue. European Heart Journal. 34(suppl 1). P3262–P3262. 3 indexed citations
13.
Shimabukuro, Michio, Daiju Fukuda, Takeshi Soeki, et al.. (2012). Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice. Cardiovascular Diabetology. 11(1). 139–139. 56 indexed citations
14.
Hirata, Yoichiro, Hirotsugu Kurobe, Chika Nishio, et al.. (2012). Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury. European Journal of Pharmacology. 699(1-3). 106–111. 46 indexed citations
15.
Shimabukuro, Michio, Daiju Fukuda, Takeshi Soeki, et al.. (2012). Activation of AMPK–Sirt1 pathway by telmisartan in white adipose tissue: A possible link to anti-metabolic effects. European Journal of Pharmacology. 692(1-3). 84–90. 24 indexed citations
16.
Hirata, Yoichiro, Hirotsugu Kurobe, Etsuko Uematsu, et al.. (2012). Beneficial effect of a synthetic prostacyclin agonist, ONO-1301, in rat autoimmune myocarditis model. European Journal of Pharmacology. 699(1-3). 81–87. 7 indexed citations
17.
Hirata, Yoichiro, Michio Shimabukuro, Etsuko Uematsu, et al.. (2011). A synthetic prostacyclin agonist with thromboxane synthase inhibitory activity, ONO-1301, protects myocardium from ischemia/reperfusion injury. European Journal of Pharmacology. 674(2-3). 352–358. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiang Shi-sen Breakdown of academic impact, for papers by Quanzhong Li Breakdown of academic impact, for papers by Ben He Breakdown of academic impact, for papers by Xiaolei Bi Breakdown of academic impact, for papers by Samuele Ambrosini Breakdown of academic impact, for papers by Mohanad Gabani Breakdown of academic impact, for papers by Yehoshua C. Levine Breakdown of academic impact, for papers by Maura Knapp Breakdown of academic impact, for papers by Katsunobu Kobayashi Breakdown of academic impact, for papers by Wenjuan Liu
Rankless by CCL
2026